Novel Drugs in Development for Malignant Mesothelioma
- 作者Kavita Maung; Michael C. Perry; Harvey Pass; Mark Kris; Mark Socinski; Vinay K. Jain; Chandra P. Belani
- 卷第4卷
- 期第3期
- 印刷ISSN1525-7304
- 电子ISSN1938-0690
- 文件大小140.89KB
- 发表时间2002
- DOI10.1016/s1525-7304(11)70551-4
- 页码146-148
Evolving Role of Topotecan in Treating Small-Cell Lung CancerG. Kesava Reddy; Chandra P. Belani; Vinay K. Jain · 2004
Current Data and Ongoing Trials in Patients with Recurrent Non–Small-Cell Lung CancerG. Kesava Reddy; Chandra P. Belani; Vinay K. Jain; Michael C. Perry · 2004
2005 Highlights From: 41st Annual Meeting of the American Society of Clinical Oncology Orlando, FL, May 2005Angelia D. Gibson; Jubilee Stewart; G. Kesava Reddy; Tara Beers Gibson; Chandra P. Belani; Vinay K. Jain · 2005
2005 Highlights From: 96th Annual Meeting of AACR Anaheim, CA, April 2005 41st Annual Meeting of ASCO Orlando, FL, May 2005G. Kesava Reddy; Chandra P. Belani; Vinay K. Jain · 2005
Mutations in the Epidermal Growth Factor Receptor Tyrosine Kinase May Predict Response to Gefitinib in Non–Small-Cell Lung CancerG. Kesava Reddy; Chandra P. Belani; Vinay K. Jain · 2004
Paclitaxel Poliglumex/Carboplatin Is Similar to Paclitaxel/Carboplatin as First-Line Treatment in Elderly Patients with Advanced Non–Small-Cell Lung Cancer and a Poor Performance StatusG. Kesava Reddy; Chandra P. Belani; Vinay K. Jain · 2005